Monitoring Tissue Engineering Using Magnetic Resonance Imaging by Xu, Huihui et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Biological Systems Engineering: Papers and 
Publications Biological Systems Engineering 
12-2008 
Monitoring Tissue Engineering Using Magnetic Resonance 
Imaging 
Huihui Xu 
Department of Applied Biology and Biomedical Engineering, Rose-Hulman Institute of Technology 
Shadi F. Othman 
University of Nebraska-Lincoln, sothman2@unl.edu 
Richard L. Magin 
University of Illinois at Chicago, 851 South Morgan St., Chicago, IL 
Follow this and additional works at: https://digitalcommons.unl.edu/biosysengfacpub 
 Part of the Biological Engineering Commons 
Xu, Huihui; Othman, Shadi F.; and Magin, Richard L., "Monitoring Tissue Engineering Using Magnetic 
Resonance Imaging" (2008). Biological Systems Engineering: Papers and Publications. 54. 
https://digitalcommons.unl.edu/biosysengfacpub/54 
This Article is brought to you for free and open access by the Biological Systems Engineering at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biological Systems 
Engineering: Papers and Publications by an authorized administrator of DigitalCommons@University of Nebraska - 
Lincoln. 
Approximately one person in five in the United States 
will require organ replacement therapy before reaching 65 
years of age (1). Physicians now treat organ failure either by 
surgically transplanting tissues or by replacing living tissue 
with mechanical/electrical devices such as artificial joints, 
vascular stents, or pacemakers. However, transplants rely on 
the availability of a compatible donor while biomechanical 
devices wear out and must be replaced. Tissue engineering 
provides a third option for patients; an option that is the fo-
cus of regenerative medicine. In regenerative medicine new 
sources of replacement tissues are used, sources that are not 
surgically transplanted, but assembled de novo from a three-
dimensional porous scaffold imbedded with stem cells and 
essential growth factors. Directing this process is possible 
only if the tissue engineer has a clear picture of all the indi-
vidual components: cells, extracellular matrix, and biochem-
ical growth modulators. Optical and fluorescent microscopy 
can be used to monitor tissue growth, but even multi-pho-
ton techniques have a limited depth of field—generally up 
to hundreds of microns or one millimeter (2). Micro-CT 
solves the penetration problem but uses ionizing radiation 
and requires dense tissue to provide contrast (3). Much cur-
rent interest is directed towards magnetic resonance imag-
ing (MRI), which uses non-ionizing radiation and has the ca-
pability of imaging thin slices of tissue in any orientation, at 
any depth, and with submillimeter resolution.
As tissues grow, morphogenesis alters their physical and 
chemical properties. Changes in tissue hydration, macromo-
lecular content, or water/lipid ratios, for example, are re-
flected in MRI as contrast in phase, diffusion, or relaxation 
time weighted MR images. In addition, high resolution MRI 
(slices less than 100 μm) can be used to characterize the struc-
ture and composition of regenerating tissues with resolu-
tion approaching that of individual cells, with the aid of high 
field systems above 7 T. Current applications of MRI in tis-
sue engineering span a range from the investigation of mes-
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Abstract
Assessment of tissue regeneration is essential to optimize the stages of tissue engineering (cell proliferation, tissue development 
and implantation). Optical and X-ray imaging have been used in tissue engineering to provide useful information, but each has 
limitations: for example, poor depth penetration and radiation damage. Magnetic resonance imaging (MRI) largely overcomes 
these restrictions, exhibits high resolution (approximately 100 μm) and can be applied both in vitro and in vivo. Recently, MRI 
has been used in tissue engineering to generate spatial maps of tissue relaxation times (T1, T2), water diffusion coefficients, and 
the stiffness (shear moduli) of developing engineered tissues. In addition, through the use of paramagnetic and superparamag-
netic contrast agents, MRI can quantify cell death, assess inflammation, and visualize cell trafficking and gene expression. After 
tissue implantation MRI can be used to observe the integration of a tissue implant with the surrounding tissues, and to check for 
early signs of immune rejection. In this review, we describe and evaluate the growing role of MRI in the assessment of tissue en-
gineered constructs. First, we briefly describe the underlying principles of MRI and the expected changes in relaxation times (T1, 
T2) and the water diffusion coefficient that are the basis for MR contrast in developing tissues. Next, we describe how MRI can be 
applied to evaluate the tissue engineering of mesenchymal tissues (bone, cartilage, and fat). Finally, we outline how MRI can be 
used to monitor tissue structure, composition, and function to improve the entire tissue engineering process.
Keywords: tissue engineering, regenerative medicine, magnetic resonance imaging (MRI), elastography, organogenesis, bone, fat, 
cartilage, mesenchymal stem cell
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enchymal stem cell differentiation in culture and bulk cell 
expansion in bioreactors to studies in whole animals moni-
toring the growth of implanted bone, fat, or cartilage tissues. 
In order to better understand the role of MRI in tissue engi-
neering and regenerative medicine, this review will: (i) de-
scribe the physical basis for MR contrast in developing tis-
sues, (ii) highlight recent MRI studies of tissue engineered 
constructs, and (iii) outline new areas for future research and 
development.
Principles of tissue engineering
Tissue engineering seeks to create biological substitutes 
that restore, replace, or regenerate defective tissues and their 
function (4, 5). Successful tissue engineering requires healthy 
expandable cells, a porous biocompatible scaffold, biochem-
ical growth factors, and a favorable physiological environ-
ment for tissue regeneration (6, 7). Cell sources, based on 
their origin, fall into three categories: autologous cells from 
the patient, allogeneic cells from another human donor, and 
xenogeneic cells from other species. Each cell source ulti-
mately is derived from either embryonic stem cells or adult 
differentiated stem cells (4). Differentiated adult stem cells 
have the shortcoming that only a limited number of cells can 
be harvested from the patient, and harvesting cells causes 
trauma and tissue damage. These shortcomings have limited 
the clinical application of adult differentiated stem cells (8). 
On the other hand, embryonic stem cells, with proper induc-
tion, can differentiate into many tissues (mesenchymal stem 
cells, for example, into fat, bone, cartilage, muscle, ligament, 
tendon, and marrow stroma), and following in vitro culture 
and expansion can potentially provide an unlimited supply 
of cells for tissue transplantation. Current medical practice 
could use engineered tissues to treat a variety of diseases (for 
example, skin ulcers, joint defects, diabetes, cardiac valve 
failure, osteogenic tissue loss, and liver disease) (9, 10). How-
ever, before clinicians can apply engineered-tissues in regen-
erative medicine, the ethical and practical issues of human 
embryonic stem cells must be resolved, and the procedures 
for stem cell collection, expansion, differentiation and im-
plantation must be perfected. In this paper we will show 
how magnetic resonance imaging (MRI) can be used to en-
hance tissue engineering through improved monitoring of 
cell growth and tissue development.
The strategy for using mesenchymal stem cells in tissue 
engineering is illustrated in Figure 1 for a bone replacement 
implant in a mouse. Following the successful collection of 
cells from donor bone marrow, the cells are expanded in cell 
culture and either compacted into a pellet or seeded into an 
artificial scaffold. Scaffolds are typically fabricated from nat-
ural-derived (for example, agarose, alginate, or collagen) or 
synthetic biomaterials (for example, polymers such as poly-
glycolic acid or hydrogels). The scaffold provides a bioactive 
framework for cell proliferation and differentiation. Scaffolds 
must have a high ratio of cell accessible space to total volume 
(diffusivity, porosity), with pore sizes greater than 10 mi-
crons to facilitate cell seeding and the diffusion of nutrients. 
In addition, the scaffold should exhibit sufficient mechanical 
strength to support the surrounding tissues, initially at the 
time of transplantation, and subsequently for the duration of 
the healing process. Finally, proper tissue development re-
quires biodegradability of the scaffold and the timely appli-
cation of tissue differentiation and growth stimulation fac-
tors. This entire process typically begins with cells growing 
in culture or in a specially designed bioreactor (for a period of 
weeks) and then proceeds in the animal or patient for months 
after implantation (11). In order to ensure optimal growth, 
the tissue engineer needs regular feedback about the struc-
ture, composition, and strength of the developing tissues. In 
the following sections, we describe how such information can 
be acquired using MRI for tissue engineered bone, cartilage 
and fat, but first we will summarize the basic principles un-
derlying MRI and the key parameters that affect image qual-
ity, resolution and contrast.
Principles underlying image contrast in MRI
MRI is a sensitive method for visualizing structural and 
functional changes in biological tissues (12). For example, 
as tissues develop, die, or regenerate, the local environment 
of the tissue water—the source of the MR signal—changes. 
Such changes are reflected in MR images through local vari-
ations in the amount of tissue water, its physical state (e.g., 
freely diffusing or protein bound), and its nuclear magnetic 
Figure 1. A flow diagram for bone tissue engineering. After isolation from bone marrow, mesenchymal stem cells (MSCs) are allowed to prolifer-
ate in vitro. The cells are then seeded into the biocompatible scaffold along with growth and differentiation factors (for example, β-glycerophos-
phate and ascorbic acid). The cells continue to grow and differentiate in an incubator or bioreactor. Upon maturity, the engineered tissue is trans-
planted into the animal or patient.
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resonance (NMR) relaxation times (T1 and T2). The dynam-
ics of these changes in tissue water are captured in MRI by 
the Bloch equation: a phenomenological equation describ-
ing the physics of magnetic moments—such as the magnetic 
moment of the water proton—as a precessional gyroscopic 
motion in the presence of exponential damping (T1 and T2), 
perturbing magnetic fields (the fixed, B0 and the time-vary-
ing radiofrequency, B1), and magnetic field gradients (Gx, Gy, 
Gz). The reader is directed to the book “Magnetic resonance 
imaging: physical principles and applications” by Kuperman 
(13) for a concise description of the physics underlying the 
Bloch equation and for a discussion of the prevailing tech-
niques used to acquire and display MR images. Here we will 
only illustrate the process diagrammatically (Figure 2) via 
the connections between the MRI imaging system, the image 
acquisition pulse sequence, and the reconstructed MRI im-
age/display. MRI begins with selection of the pulse sequence 
parameters in an imaging protocol (Figure 2) that specify the 
field of view, signal-to-noise ratio and spatial resolution. The 
pulse repetition time, TR, defines the time period over which 
the tissue water can recover its observable magnetization; 
the echo time, TE, is the time period after the initial radio 
frequency pulse when the signal (echo) is recorded; and the 
magnetic field gradient pulses (Gx, Gy, Gz) give spatial local-
ization for the NMR signal in the sample. For the spin echo 
sequence described in Figure 2, the signal intensity is propor-
tional to the local water concentration multiplied by the ex-
ponential decay expression (1-e−TR/T1)e
−TE/T
2. Thus, changes 
in tissue during growth that affect the amount of water or 
change its T1 or T2, for fixed values of TR and TE, will al-
ter the magnitude and phase of the detected MR signal. Re-
gions of the image exhibiting different signal intensities are 
revealed as contrast in the image.
In a digital MR image, the field of view (FOV) for single 
slice can be decomposed into individual picture elements 
(pixels) that determine the resolution of the image. The re-
lationship between pixels and FOV in the x and the y di-
rections, for example, is simply: FOVx = NxΔx and FOVy = 
NyΔy, where Nx and Ny are typically 128 or 256. Acquisition 
of an MR image involves sampling the detected NMR signal 
for each of the slices of the object under study. The mathe-
matics of sampling requires the sampling intervals to be less 
than two times the reciprocal of maximum frequency (Ny-
quist sampling criterion). This constraint gives the following 
simple relationships between MR imaging parameters, and 
the resolution for rectilinear sampling (13) for the spin echo 
pulse sequence shown in Figure 2.
Δx = FOVx ÷ Nx = 2π ÷ Nx γ Gx Tacq                         (1)
Δy = FOVy ÷ Ny = 2π ÷ Ny γ Gy Tpe                          (2)
In these expressions γ/2π is the gyromagnetic ratio (42.58 
MHz/T for water protons), Gx and Gy are the magnitude of 
the x (read) and y (phase) encoding gradients (typically, 1–
200 G/cm), and Tacq and Tpe are the duration of the acqui-
sition window (typically 1–10 ms) and the phase encoding 
gradient (typically, ≤5 ms), respectively. From these equa-
tions it follows that stronger gradients (Gx, Gy, Gz) improve 
the achievable resolution (typically 50 to 500 microns). The 
slice location and thickness are determined by modulation of 
the transmitted radio frequency pulses (B1 in Figure 2). For 
the typical sinc pulse modulation the slice thickness is given 
Figure 2. The block diagram of a typical MRI system with the components, pulse sequence and image display highlighted. When an animal, human 
or tissue sample is placed in a magnetic field (B0), the magnetic moment of the protons in the nucleus of the hydrogen atoms of the water precess at 
a frequency dependent upon the strength of the magnetic field, f0 = γβ0/2π where γ/2π = 42.57 MHz/Tesla for hydrogen; f0 for protons is typically 
in the range of 50–500 MHz. The magnetic moments align in a direction parallel to the main field establishing a net magnetization in the tissue wa-
ter. A radio frequency (RF) coil produces a B1 field that changes the direction of the magnetization in a manner prescribed by the pulse sequence 
(for example, 90° and 180°). Following the RF pulses, the radio frequency coil detects the return of the magnetization to thermal equilibrium. Spatial 
localization is generated with the use of the gradient coils (Gx, Gy, Gz). Variation of the repetition time (TR) and the echo time (TE) in the MR pulse 
sequence provides the basis for different contrast mechanisms. For example, a long TR and a short TE will produce a T1 weighted image based on 
the MR properties of the imaged sample. Other conditions can generate T2, proton density or diffusion weighted images. The MR signal is acquired 
as a complex quantity (magnitude and phase). The magnitude is sufficient to depict anatomical features, measure tissue relaxation times or estimate 
the apparent water diffusion coefficient, while the phase can be used to measure blood flow, tissue temperature and tissue stiffness.
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by
Δz = 4π ÷ γ Gz τp                                              (3)
where τp is the duration of the 90° B1 pulse (typically 5 ms).
The signal-to-noise ratio (SNR) associated with MR imag-
ing can be summarized by the expression 
SNR µ B
0
2VsN                                                 (4)
where B0 is the strength of static magnetic field, Vs is the vol-
ume of the sample and N is the number of acquisitions (14). 
High field MRI (3 Tesla and above) thus directly improves 
the SNR and allows faster imaging without compromising 
the resolution. The ability to distinguish individual pixels in 
a given MR image is known as contrast. Since image noise 
often limits the achievable contrast, a figure of merit used 
to characterize image contrast is the contrast to noise ratio 
(CNR), defined for two tissue regions A and B as
CNR = (SNRA – SNRB) ÷ Noise                     (5)
Contrast, thus depends on increasing the relative difference 
between the signal intensities of two adjacent regions of an 
image and reducing the overall noise level. The noise can be 
estimated from the expression 
Noise = (4kB T Δf R)1/2                                    (6)
where kB is the Boltzman’s constant, T is the absolute tem-
perature, Δf is the detector’s frequency bandwidth and R is 
the overall resistance of the loaded RF coil.
Optimal tissue contrast relies on selection of an appro-
priate imaging strategy to highlight the intrinsic differ-
ences between various tissues. Basic tissue contrast arises 
from the relative abundance of the hydrogen nuclei un-
der investigation, that is, water content, and the two relax-
ation times: spin-lattice relaxation T1 and spin-spin relax-
ation T2 (12). Advanced contrast methods include injection 
of paramagnetic contrast agents such as Gd-DTPA, and the 
use of MR techniques that are sensitive to water diffusion 
in the tissue (13, 14). An example of current animal work 
using contrast agents is the study by Ko and coworkers 
(15), where the investigators demonstrated that MRI could 
be used to monitor and track transplanted cells in vivo. In 
this preliminary study human bone marrow-derived MSCs 
were labeled with super paramagnetic iron oxide, a strong 
T2 contrast agent. After the cells were embedded in a gel-
atin sponge the construct was implanted subcutaneously 
at the right proximal thigh of a 6 week-old nude mouse. 
MR images confirmed that cell labeling could be observed 
in living animals; a critical first step in establishing in vivo 
monitoring.
Methods to Enhance Image Contrast in MRI
Water, the principal source of the signal detected in MRI, 
occupies multiple tissue compartments (for example, intra-
vascular, extracellular, intracellular) where diffusion and 
tissue heterogeneity modulate water’s complex interac-
tions with proteins, macromolecules and membranes. Lo-
cal changes in the bulk water distribution and the compart-
mental T1 and T2 relaxation measurements do not always 
give specific measures of tissue complexity; hence, other 
techniques are needed to provide a complete picture of the 
changing dynamics occurring during tissue growth. Diffu-
sion weighted MRI, magnetization transfer (MT) contrast 
and T1ρ relaxation, for example, are MR techniques that can 
provide additional information about tissue structure and 
composition. In addition, chemical shift imaging and MRI-
based tissue elastography can be used to measure the chemi-
cal and physical properties, respectively, of individual tissue 
compartments. Here we describe the basic principles under-
lying these advanced contrast methods in MRI. Additional 
details can be found in the cited references.
Diffusion contrast — When implanted cells proliferate and 
become organized into tissue the overall diffusion of water 
decreases because the molecules encounter additional phys-
ical barriers (16). Diffusion weighted MRI provides a means 
to identify the emerging tissue structure through the reduc-
tion of the apparent diffusion coefficient. The mechanism 
underlying diffusion weighted imaging is the application 
of a sequence of two short duration (δ) gradient pulses of 
opposite polarity that are separated by a delay time (Δ). In 
the absence of diffusion the two pulses induce small phase 
shifts that compensate for each other, but when diffusion oc-
curs the cancellation is incomplete and additional signal at-
tenuation arises; typically the signal is attenuated according 
to e−bD, where b = (γGzδ)2Δ for Δ>>δ and b is determined 
from the area (Gzδ) and separation (Δ) of the applied gradi-
ent pulses. By stepping b over a range from 100 to 2000 s/
mm2 or higher the exponential signal decay can be plotted 
and the apparent diffusion coefficient, D, determined for the 
tissue (16). In isotropic, but heterogeneous tissue, D changes 
with location but is independent of direction; hence, a single 
value of D is sufficient to characterize the diffusion of each 
voxel. When the tissue environment is anisotropic, however, 
such as in white matter of the brain or in articular cartilage, 
D is described by a 3×3 matrix or diffusion tensor (16). Dif-
fusion weighted and diffusion tensor imaging are typically 
conducted at submillimeter resolution, providing spatial 
maps of the apparent water diffusion coefficient. In diffu-
sion weighted MRI the diffusion data are often presented as 
diffusion ellipsoids, which can be calculated for each voxel, 
such that by their eccentricity and orientation the paths of 
preferred diffusion can be identified (16).
Magnetization transfer contrast — Magnetization transfer 
contrast depends on the exchange of magnetization between 
the protons (H nuclei) of free water and water bound to pro-
teins and other macromolecules (17). In this technique, an off 
resonance radio frequency pulse is applied, which ideally 
eliminates the signal associated with macromolecular water. 
Subsequent interaction and exchange between the two wa-
ter pools give a signal that reflects the distribution of macro-
molecules in the tissue—via the magnetization transfer ratio 
(MTR). Magnetization transfer is currently used in MR angi-
ography to attenuate the signal from brain tissue and to im-
prove contrast between blood vessels and surrounding tis-
sue (18). The MTR is also sensitive to the structural changes 
that occur in cancer, arthritis and multiple sclerosis. For ex-
ample, in a study by Brochet and Dousset (19), a reduction 
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in the MTR was found in demylinated lesions, and that de-
crease was proportional to the level of myelin loss. In carti-
lage tissue engineering we would anticipate an increase in 
MTR with the incorporation of collagen and proteoglycans in 
developing cartilage (20).
T1r contrast — T1r is a relaxation parameter that is sensitive 
to molecular processes occurring at a much lower frequency 
range than those associated with T1 relaxation (kHz instead 
of MHz). T1r measurements are essentially T1 measurements 
performed while the radio frequency B1 pulse is left on for 
the entire relaxation period. T1r values reflect the macromo-
lecular content of the tissue more strongly than T1 relaxation 
times. T1r contrast arises, for example, when the collagen ma-
trix is disrupted in diseased cartilage. In a recent study of 
cartilage, for example, a statistically significant change in T1r 
was observed between native and enzymatically treated car-
tilage (21). Changes of T1r were also observed in proteogly-
can-depleted cartilage, indicating T1r sensitivity to proteo-
glycan content (22).
Chemical shift — Chemical shift imaging separates signals 
from each chemical component in a tissue (23). The separa-
tion is based on the small difference between the individual 
resonance frequencies for hydrogen atoms associated with 
water or with lipids. For example, between fat lipids and wa-
ter, there is a frequency shift of approximately 450 Hz (at 3.0 
T). By applying frequency selective radio frequency pulses 
it is possible to excite individual hydrogen nuclei in tissue. 
Since the methylene (-CH2-) group is typically associated 
with fat while the surrounding water contain free and bound 
water the two pools can be separated by their characteris-
tic frequencies. Thus, chemical shift imaging provides sepa-
rate images for each tissue component. Chemical shift imag-
ing can also be used either to suppress the fat signal in MRI 
or to highlight the development of adipose tissue in tissue 
engineering.
Magnetic resonance elastography — Stiffness or elasticity 
is an intrinsic mechanical property of biological tissues that 
changes in disease, with recovery from injury, and as tis-
sue regrows or regenerates. Magnetic resonance elastogra-
phy provides maps of tissue stiffness from the analysis of a 
phase contrast MR image acquired while applying a low fre-
quency mechanical shear wave (typically with amplitudes of 
less than 100 μm and frequencies of 100–1000 Hz). The peri-
odic vibrations are synchronized with the MR image acquisi-
tion (24) and motion encoding gradients stepped in sequence 
to provide shear wave motion images that can be analyzed 
to extract tissue elasticity maps (stiffness and viscosity). Bulk 
elastic parameter data can be used to assess developing pa-
thology and tissue regeneration. For example, in the recent 
study by Cheung and associates, MR elastography was used 
to observe changes in the shear modulus of plantar fat pads 
in diabetics (25).
Bone Tissue Engineering
Trauma, osteoporosis, and cancer lead to over two mil-
lion cases of bone injury or loss in the United States each 
year (26). Natural bone healing following injury or disease 
is the preferred option to overcome osteogenic tissue loss 
and bone damage. However, since bone has a limited capa-
bility to regenerate and remodel, it is often the case that the 
surgeon will need to implant synthetic materials or bone 
grafts at the site of injury. Approximately one million cases 
of bone grafting are performed each year in the United 
States to treat non-union following fracture, at an estimated 
cost of over $3 billion per year (26). Both autologous and al-
logeneic bone grafts are used clinically as bone substitutes; 
however, the availability of compatible bone grafts is lim-
ited because harvesting bone is painful and the procedure 
carries the risk of infection. Therefore, alternative tissue 
sources are needed.
Bone is a dense connective tissue with a strong calcified 
outer layer (cortical bone) that comprises more than three 
fourths of the bone mass. Cortical bone has a relatively low 
porosity, ranging from 5% to 10% (porosity is a measure of 
the available fluid volume of bone, and can be determined 
from the ratio of dry to fresh, wet bone weight). The soft in-
ner spaces of bone (usually described as cancellous or trabec-
ular bone) form the remaining one fourth of the bone mass. 
Cancellous bone has a high porosity (ranging from 60% to 
90%) and contains the bone marrow, which consists of blood 
stem cells, adipose cells, osteoblasts, and osteocytes. Osteo-
blasts are essential for the deposition and mineralization of 
the extracellular matrix of new bone while osteocytes are the 
supporters for bone matrix calcification. Specific growth fac-
tors and proteins, mainly residing in the extracellular matrix 
of bone, are responsible for regulating cellular activity and 
stimulating the intracellular environment. The factors and 
proteins that the tissue engineer must control include trans-
forming growth factor-beta (TGF-beta), insulin-like growth 
factors (IGF) I and II, fibroblast growth factor (FGF), and 
bone morphogenetic proteins (BMPs) (27).
Replacing the natural repair processes in bone is the goal 
of bone tissue engineering. To achieve this goal a source of 
bone forming cells must be found and a means of physi-
cally supporting these cells in a structural scaffold devel-
oped. Bone marrow stromal cells, also called mesenchymal 
stem cells (MSCs), can be stimulated to differentiate into os-
teoblasts, chondrocytes and adipocytes, and thus they can 
provide a potential source for bone progenitor cells (28). 
Biocompatible scaffolds of bone tissue engineering should 
be mechanically stiff, porous, and moldable (28). Commer-
cially available bone scaffolds vary in composition, span-
ning a range that includes ceramics, metals, polymers, and 
natural materials (26). Natural biodegradable polymers 
are often used because they integrate most easily with sur-
rounding tissues (28). Researchers have been successful 
using MSCs to regenerate bone in bioreactors, in animal 
models and in clinical trials. X-ray and micro-CT imaging 
techniques are most suitable for viewing solid bone growth, 
but early bone tissue development can be monitored using 
conventional MRI and the new ultra short TE methods, un-
der development (29).
MRI of bone — Cortical bone is not visible in conventional 
MRI. Bone appears dark because of the relatively low num-
ber of hydrogen atoms in the bone mineral and the very short 
T2 relaxation time of the solid material: cortical bone has an 
average T2 of 250–500 μs (30). Bone can be imaged, using ul-
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trafast MR imaging sequences that capture the data quickly 
(in less than 1 ms after excitation), but such techniques are 
not widely available and require special high speed imaging 
hardware (30, 31). Therefore, the predominant features vis-
ible in MR images of bone reside in the bone marrow (Fig-
ure 3). Contrast in the bone marrow reflects the micro-archi-
tecture and its fat/water composition. However, special care 
must be taken when viewing the interface between the mar-
row and the surrounding solid bone tissue where the transi-
tion between the marrow and cortical bone can induce mag-
netic field artifacts and distort the MR image.
Progress in monitoring tissue-engineered bone in vitro — 
X-ray micro-tomography (micro-CT) of cortical bone exhibits 
high resolution and contrast; however, the X-ray contrast is 
less apparent in the marrow and in newly formed bone prior 
to mineralization. Thus, MRI, with its superior soft tissue 
contrast, can be expected to provide greater detail in images 
of the beginning stages of bone growth. Such results were in 
fact observed in an in vitro study comparing micro-CT and 
9.4 T MRI by Washburn and coworkers (32). In this study 
of bone formation a porous polyethylmethacrylate scaffold 
was seeded with primary chick osteoblasts. Growth was as-
sessed over an 8 week period by following the loss of MR 
signal in proton density MR images and the appearance of 
solid bone contrast in the micro-CT images. A similar pro-
gressive decrease in the MR signal was observed by Xu and 
coworkers (33) in a 4-week study of osteogenesis by MSCs 
embedded in a gelatin scaffold. Xu used 11.7 T MRI to mon-
itor bone formation and found a linear relationship between 
the concentration of bone minerals, such as calcium, and the 
T1 and T2 relaxation times. In Xu’s study the T2 was reduced 
by over 50% as the bone developed (Figure 3); a T2 decrease 
similar to that observed by Washburn and coworkers (32). 
In both the Xu and the Washburn studies the observed de-
crease in relaxation times correlated with bone mineral de-
position—as measured by histological analysis (calcium 
composition and alkaline phosphatase activity). Also, both 
groups reported that the apparent diffusion coefficient de-
creased, likely reflecting the increase in structure (interfaces 
and barriers to diffusion) of the engineered bone tissue. On 
the other hand, in another bone growth study using MR mi-
croscopy at 9.4 T Chesnick and associates (34) found that the 
T2 values increased. This research monitored mineralization 
in a hollow fiber bioreactor seeded with embryonic chick os-
teoblasts. Proton density MR images as well as T2 relaxation 
time and magnetization transfer ratio maps were obtained 
with a 78 μm resolution for 1 mm slices. The magnetiza-
tion transfer ratio was found to change with mineralization 
Figure 3. (A) An illustration of the anatomical structure of a long and cancellous bone, and a T1-weighted axial MR image (field strength = 11.7 T; 
spin echo sequence TR/TE = 500 ms/7 ms, slice 1 mm) through a cylindrical osteochondral plug excised from the distal femoral condyle. (B) T1/
T2 bar chart and high resolution axial MR images for tissue engineered bone (33) over a 4-week period. The relaxation time data show that T2 is 
a good marker for studying the development of the construct while T1 is less sensitive. The high resolution images were acquired with acquisi-
tion parameters: TR = 1 s; TE = 30 ms; slice thickness = 0.5 mm; field of view (FOV) = 0.8 cm × 0.8 cm; in-plane resolution = 62.5 μm × 62.5 μm; and 
number of averages N = 8. The MR images show the consolidation of the construct (diameter decreases by 50%) and a fall in overall signal inten-
sity with the incubation time. Relaxation times are represented by average ± std (sample size n = 7).
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in bone constructs, that is, higher values were observed in 
the mineralized zone and non-uniform but lower values in 
the superficial region. These results illustrate the complex-
ity of monitoring bone formation in different systems, hence 
the need for MR microimaging, quantitative parameter mea-
surements and histological controls.
An important measure of bone development is me-
chanical strength. MR elastography is able to assess tensile 
strength through measurements of bone stiffness and elastic-
ity. In a study of bone development by Othman and cowork-
ers (35), MR elastography was used to characterize the early 
stages of bone formation in gelatin scaffolds embedded with 
MSCs. This study measured the shear stiffness of develop-
ing bone over a two week period. Compared with controls, 
a three- to fourfold increase in shear stiffness was reported 
during the initial stages of growth: 11.88±0.4 kPa at week 
1 and 15.8±0.5 kPa at week 2 for the treated groups (com-
pared with 4.1±0.3 kPa at week 1, and 3.6±0.4 kPa at week 
2 for controls). Othman’s study also revealed a non-uniform 
growth of bone components within the sample, and consid-
erable variation of the MR parameters from region to region. 
Such results could reflect either non-uniform seeding of stem 
cells in the scaffold or a problem with the distribution of nu-
trients and growth factors.
Progress in monitoring tissue-engineered bone in vivo — 
As in vitro tissue engineering methods are perfected there 
will be an increasing need for in vivo monitoring of implants, 
first in animals and later in human clinical trials. In an an-
imal study by Hartmen and associates (36), MRI was used 
to assess the growth and development of bone. Using a rat 
model, Hartmen employed high resolution MRI at 7.1 T to 
monitor ectopic bone formation over a 7-week period. The 
post-implantation MR and X-ray images, and histological re-
sults, confirmed that MRI could detect small changes in bone 
growth (0.5 mm in diameter), as well as display the com-
plete 3D shape of the newly formed bone. In another bone 
growth study using an athymic mouse model, Potter and co-
workers (20) used MR microscopy to evaluate the growth 
and development of tissue engineered phalange constructs. 
MR microscopy images at week 38 showed the engineered 
specimen to be about 3 mm longer and more heavily miner-
alized than controls. In this study, an inverse linear relation-
ship was found between mineral concentration measured by 
X-ray micro-CT and tissue hydration as measured by MR mi-
croscopy at 9.4 T. Such animal studies show that MRI can be 
used to monitor the progressive changes of engineered bone 
that occur over a period of months and that MRI can serve as 
a complement to micro-CT (37).
Cartilage Tissue Engineering
A major degenerative disease of articular cartilage is os-
teoarthritis. Osteoarthritis affects approximately 70 mil-
lion people in the United States and is the leading cause of 
chronic disabilities in people over 50 years of age (38). The 
cost of treating arthritis and related conditions in the United 
States is over 65 billion dollars per year (39). Current carti-
lage restoration therapies rely on either tissue grafts or engi-
neered cartilage substitutes. Replacement tissue grafts (auto-
grafts or allografts) have a success rate of approximately 70% 
after two to five years (40). However, cartilage grafts have 
the common shortcomings of all transplant therapies: do-
nor availability, donor site morbidity (due to excessive tissue 
loss) and the possibility of pathogen transmission (39). Engi-
neered cartilage substitutes, when fully developed, have the 
potential to overcome these limitations.
Articular cartilage is a thin heterogeneous tissue with a 
thickness typically less than 2 mm that coats skeletal joint 
surfaces. Cartilage consists of collagen—mostly in the form 
of type II collagen—and proteoglycans. Articular cartilage 
has four distinct zones: the superficial zone with collagen fi-
brils oriented along the cartilage surface (approximately 5–
10% of thickness in humans), the transitional zone with 
randomly oriented collagen (approximately 40–45% of thick-
ness), the radial zone with radially oriented collagen (ap-
proximately 40–45% of thickness), and the deepest calcified 
zone, which has little collagen and acts as a transition region 
between the soft hyaline cartilage and the stiffer subchondral 
bone (approximately 5–10% of thickness). Each of the four 
zones has different biomechanical properties that are consis-
tent with their structure and function (41).
Cartilage tissue engineering has the goal of reestablishing 
the natural state in damaged cartilage. The process first in-
volves introducing progenitor cells into the injured site, with 
or without a scaffold. The best source of cells for cartilage re-
pair is an area of active investigation; both chondrocytes and 
stem cells are widely used in cartilage tissue engineering. 
The primary advantage of chondrocytes is that they imme-
diately begin to secrete cartilage-specific extracellular matrix 
components and thus can more rapidly form cartilage-like 
tissue (<2 months) (39, 40). In orthopedic clinics, implanta-
tion of a suspension of cultured autologous chondrocytes is 
becoming an established technique for the treatment of joint 
surface defects of the knee. However, despite promising clin-
ical results, the use of chondrocytes has some limitations, 
principally due to the low expandability of chondrocytes and 
the complexity of biological responses in the periosteum (8). 
A large number of donor cells are needed to repair a large 
cartilage defect, but these cells are often not available. In con-
trast, MSCs are relatively easy to harvest, and are expand-
able from small quantities in vitro in cell culture, and can be 
induced to differentiate into chondrogenic cells (39). There-
fore, chondrogenic cells derived from MSCs are a promising 
choice for developing cartilage regeneration.
Even though cartilage is a relatively simple tissue with a 
low cell density, limited cell diversity and the absence of vas-
cular structure or nerve supply, so far, tissue engineering tech-
niques have not succeeded in producing an implant capable of 
functioning in vivo at the joint surface (42). One problem fac-
ing tissue engineers is the selection of an appropriate biolog-
ical scaffold. Natural and synthetic scaffolds are available in 
various physical forms, and compared with natural materials, 
synthetic scaffolds are easily mass-produced and free from the 
risks associated with pathogen transmission. Solid polymers 
such as polyglycolic acid or composites, such as, hyaluronan-
gelatin have also been successfully applied in chondrogene-
sis (43, 44). In addition, other groups are exploring hydrogels 
(highly hydrated polymeric systems with tissue-like water 
content) as a framework in which to encapsulate cells (45). To 
date, naturally derived collagen, the major structural compo-
nent of cartilage, has received the most attention, largely be-
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cause collagen is recognized by cellular enzymes and naturally 
degraded (46). Bioreactor systems are also under investigation 
in cartilage engineering; and an MR-compatible hollow fiber 
bioreactor system was recently employed for the production 
and development of three-dimensional hyaline cartilage from 
isolated chondrocytes (47).
MRI of articular cartilage — High resolution MRI studies 
are able to distinguish three characteristic zones in articular 
cartilage: superficial, transitional and radial (for example, see 
Figure 4). In each zone the MR signal reflects the interactions 
between water and the distribution of collagen and proteo-
glycan. Identifying the structure of cartilage via MRI could 
be an important step in assessing chondrogenesis. As an ex-
ample, consider the results shown in Figure 4 taken from a 
study by Othman and coworkers (48). In this figure a com-
parison is shown between a high resolution 11.7 T MR im-
age of normal articular cartilage and the corresponding tis-
sue histology section stained with safranin O. Over 4 weeks 
the morphological appearance of developing cartilage in the 
MR images showed a high correlation with the correspond-
ing histological sections at all stages of development (48). 
Thus, MRI can be expected to provide useful images for tis-
sue-engineered cartilage.
Progress in monitoring tissue-engineered cartilage in vitro 
— The first step in monitoring tissue-engineered cartilage is 
to quantify cell growth and tissue development in vitro. Stud-
ies by Chen and associates (11), Greco and Spencer (49) and 
Potter and coworkers (47, 50) used 9.4 T MRI to monitor hy-
aline cartilage growth in a hollow fiber bioreactor (HFBR). 
All these researchers found a strong correlation between bio-
chemical markers (e.g., tissue cellularity and extracellular ma-
trix composition) and MR parameters (e.g., MTR, T1, T2, and 
ADC). A novel feature of these studies was the use of a spe-
cially designed MR compatible bioreactor such that chondro-
cytes growing inside the HFBR could be monitored period-
ically over a period of weeks. Water content (via T1 and T2) 
and two main components of the cartilage matrix, namely 
proteoglycans (via Gd-DTPA enhanced imaging) and col-
lagen (via MTR), were assayed. For example, the average T2 
value decreased from 60 ± 4 ms at week 1 to 35 ± 5 ms at week 
4; values comparable with those obtained at the same field 
strength for natural articular cartilage by Nieminen and co-
workers (51). In addition, the measured MTR value at week 1 
was similar to that measured for a control collagen gel, while 
the MTR value measured at week 4 was close to the value re-
ported in the literature for bovine articular cartilage (52). In 
the study by Potter and coworkers (50), tissue heterogeneity 
was observed in both the MTR and T2 data while such hetero-
geneity is not seen in normal articular cartilage (51). Thus, the 
MR measurements were able to identify poor tissue devel-
opment. It should also be noted that electron spin resonance 
(ESR) has been used by Spencer’s group to monitor oxygen 
consumption in cartilage growing in a HFBR (53). Further 
studies by Neves and coworkers (54) used MR microscopy 
and MR spectroscopy at 9.4 T to examine the growth of bio-
artificial meniscal cartilage tissue in vitro in a perfusion bio-
reactor. Cell-seeding density, medium selection including 
growth factors, and the application of physical stimuli, such 
as pressure and flow-induced shear stress, were manipulated 
to develop meniscal cartilages with properties approaching 
those of the native tissue. For example, the diffusion into car-
tilage of the MR paramagnetic contrast agent Gd-DTPA from 
the medium was used to assess the integrity of the develop-
ing zones (54). In this study a diffusion coefficient of 7 × 10−11 
m2/s was reported for Gd-DTPA, which is similar to the 9. 2× 
10−11 m2/s value measured by Foy and Blake in natural hu-
man articular cartilage (55).
Recent in vitro studies (56, 57) of MSCs embedded in gel-
atin and chondrocytes embedded in hydrogels used T2 maps 
and changes in the apparent water diffusion coefficient to 
characterize the development of engineered cartilage. An 
example of the changes in T2 observed is shown in Figure 4 
(Troken, A. J. et al., presented at the annual 2006 BMES Meet-
Figure 4. (A) An illustration of the anatomical structure of cartilage along with a high resolution MRI, and a histological image (Safranin-O/Fast 
green-stained section [40×) of natural cartilage (48). In the MR image, three cartilage zones can be easily identified without contrast agent enhance-
ment. The MR image acquisition parameters are: TR/TE = 1000/60 ms; field-of-view (FOV) = 0.6 cm × 0.6 cm; slice thickness = 0.5 mm; in-plane 
resolution = 22.7 μm × 22.7 μm; number of averages N = 64. Both the MRI and histological images, depict three layers representing the superficial, 
transitional, and radial zones. (B) T2 maps for engineered cartilage over a 4 week growth period. A monotonic increase of T2 is observed with time 
in this experiment (Troken, A. J. et al., presented at the annual 2006 BMES Meeting, Chicago, IL, 11–14 Oct. 2006).
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ing, Chicago, IL, 11–14 Oct. 2006). These data illustrate the 
successful use of MRI to monitor implant growth and inte-
gration with host cartilage.
Progress in monitoring tissue-engineered cartilage in vivo 
— MRI techniques have also been used in vivo to character-
ize the development of tissue engineered cartilage (58], [59, 
60). In a study by Watrin-Pinzano and coworkers (58), MR 
was used to generate T2 maps during the repair of a focal pa-
tellar cartilage defect in a rat. In this study, alginate scaffolds, 
with and without autologous chondrocytes, were implanted 
at day 0 to repair rat patellar cartilage defects. The rats were 
sacrificed sequentially (days 20, 40, and 60) after surgery, and 
the patellae cartilage samples examined ex-vivo using MRI at 
8.5 T. The T2 values derived from the MR images were found 
to discriminate between the different types of neo-cartilage; 
a result confirmed by histological analysis. In a related mul-
tinuclear NMR and MRI study by Keinan-Adamsky and as-
sociates (59) at 8.5 T using a pig model, the authors found 
that the order and the density of collagen fibers in articular 
cartilage increased from birth to maturity. This conclusion 
was derived from the bi-exponential nature of T2 relaxation 
in mature cartilage, as well as its orientational dependence 
derived from NMR spectral splittings (59). Finally, a recent 
study by Ramaswamy and coworkers (60, 61) used T2 relax-
ation data to assess the regrowth of cartilage in full-thickness 
chondral defects (surgically created) in rabbits. These studies 
demonstrate how NMR spectroscopic measurements T2 re-
laxation and MRI can be used to obtain structural and com-
positional information that contributes to a better under-
standing of the development of natural cartilage.
Adipose Tissue Engineering
Soft tissue defects also present challenges to the tissue en-
gineers. In 2006, breast cancer was the third leading cause of 
death in American women after heart disease and lung can-
cer; the cost of this disease was estimated to be over two 
hundred billion dollars a year in 2005 (62). Breast cancer and 
other cancers associated with adipose tissue leave patients 
disfigured following surgery and X-ray treatment; therefore, 
soft tissue reconstruction is an important clinical concern. In 
addition to cancer patients, trauma patients undergoing re-
constructive surgery could also benefit from improved soft 
tissue reconstruction procedures.
Adipose tissue is a specialized connective tissue that 
serves three functions: thermal insulation, energy regulation 
and mechanical cushioning. The major component of white 
adipose tissue is a loose association of lipid-filled cells (ad-
ipocytes), which are held in a framework of collagen fibers. 
Approximately 70% of the weight of white adipose tissue is 
lipid, with over 90% of the lipid in the form of triglycerides. 
Compared with other mesenchymal tissues, adipose tissue is 
less stiff and very heterogeneous.
Adipose tissue engineering via an autologous graft is the 
technique preferred by clinicians. Such grafts are immune 
compatible and convenient, but they require a donor site, 
typically from the patient’s abdomen. Allogenic or xenogenic 
grafts are also used in cases where there is the limited avail-
ability of autologous grafts. However, one major disadvan-
tage of allogenic and xenogenic grafts is possible immune re-
jection. Other strategies used for soft tissue reconstruction 
include the insertion of synthetic materials (for example, sil-
icone, saline bags), but such implants sometimes leak, de-
grade, or generate a foreign-material reaction (63).
Stem cell-based soft tissue engineering is currently under 
investigation as an alternative grafting procedure (39). Adi-
pose tissue is one of the types of connective tissue that can be 
derived from MSCs (64). In this approach, MSCs are seeded 
into the scaffold to establish a three-dimensional engineered 
construct that provides a solid framework to simulate the ex-
tracellular matrix for cell attachment and proliferation. The 
engineered cell-scaffold complexes are usually incubated in 
a supportive physical and mechanical environment that also 
provides essential nutrients, growth factors and tissue differ-
entiation reagents (65). Current adipose tissue reconstruction 
has the limitation that it is difficult to monitor graft growth 
and development. As in the case of tissue engineered bone 
and cartilage, adipose tissue development is hindered by the 
absence of non-invasive imaging methods. MRI, which has 
the capability of distinguishing between the hydrogen atoms 
in lipids and those in water, is a tool that could be used to 
monitor adipose tissue regrowth.
MRI of adipose tissue — Adipose tissue is a loose association 
of lipid-filled cells (adipocytes), which are held in a framework 
of collagen fibers. Even though adipose tissue is relatively 
simple in structure, it is challenging to image using MRI. The 
lipid and water protons behave as if they are located in two 
different compartments, each with a different resonance fre-
quency: water and lipid proton resonance differs by 225 Hz 
at 1.5 T. In addition, the protons in lipid and water have sepa-
rate relaxation times with the lipid protons relaxing via T1 and 
T2 much faster than the water protons. However, these differ-
ences in frequency and relaxation times can be used to gener-
ate fat suppressed or water and fat suppressed images where 
the lipid image is generally discarded (66).
Progress in monitoring tissue-engineered fat in vitro — MR 
microscopy at 9.4 T with and without fat suppression was 
used in a study by Potter and associates (20) to analyze the 
fat component of tissue-engineered phalanges. The fractional 
change in the image intensity was used to establish the spa-
tial distribution of mobile lipid molecules within the phalange 
constructs. Quantitative maps indicating adipose components 
were acquired 10 and 38 weeks after implantation; the fat de-
posits observed at week 38 were similar to those observed in 
histological sections. In a tissue engineering study by Mar-
ion and coworkers (Marion, N. et al., presented at the annual 
2006 BMES Meeting, Chicago, IL, 11–14 Oct. 2006) the growth 
stages of engineered fat were monitored using MR measure-
ments of relaxation times and the water diffusion coefficient. 
In this study of MSC derived adipogenic cells the T2 values 
stayed unchanged for 4 weeks, but MR elastography mea-
surements of the bulk modulus showed a significant decrease 
(Figure 5). By week 4, for example, the shear modulus had de-
creased to less than one fourth of the initial value (5.8 kPa to 
1.4 kPa). The decrease in shear stiffness indicates that the engi-
neered adipogenic tissue becomes “softer” as adipogenic ma-
trix production gradually increases. These results illustrate the 
complementary role of MRI and MR elastography in assessing 
the development of engineered tissue in vitro.
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Conclusions and Suggested Future Studies
Advances in tissue engineering will rely on improve-
ments at all stages of the tissue development process: 
choosing the cell source, selecting a biological scaffold, and 
designing the incubation system. Imaging techniques (for 
example, optical imaging, MRI, and micro-CT) are impor-
tant tools for assessing tissue regeneration at each stage of 
growth. Selection of the most appropriate imaging method 
depends on several factors: the achievable signal-to-noise 
ratio, the needed resolution, the presence or generation of 
contrast, and the desire to visualize tissue structure in a 
non-invasive manner. Ideally, imaging should provide the 
tissue engineer with complete information on tissue com-
position, structure, and function. Realistically, no single 
imaging modality can do all three. Light microscopy, for 
example, has the highest resolution but requires tissue sam-
pling, sectioning, and staining, whereas micro-CT is excel-
lent at identifying tissue calcification and bone growth, but 
has relatively poor soft tissue contrast, while MRI has the 
highest sensitivity for visualizing soft tissue, but it is tech-
nically difficult, expensive and relatively slow in acquiring 
high resolution images.
MRI, however, does provide a flexible, safe and non-inva-
sive way of measuring many parameters associated with the 
structural, biochemical and functional changes that occur in 
developing tissues. A schematic diagram illustrating the con-
nection between tissue growth, tissue properties, and differ-
ent MR-derived parameters is shown in Figure 6. Since tis-
sue growth and development change the local environment 
of the tissue water we need to observe these changes over 
hours, days and weeks as the constructs develop into mature 
tissues.
MRI has the capability of visualizing tissue develop-
ment both during the initial in vitro stages of cell culture 
and scaffold incubation and subsequently during tissue im-
plantation development in vivo, where the final integration 
of the implant—its structure and function—with surround-
ing tissues must be monitored. In the early proliferation 
stages either the incubator or bioreactor, must be brought 
to the MRI or the individual constructs must be removed 
from the incubator to be imaged. Both steps have associ-
ated technical problems that are not fully resolved. For ex-
ample, in the seeding step, the growth of cells in the scaf-
fold must be optimized, and the porosity and diffusion of 
water in the scaffold need to be examined periodically. This 
requires sequential MR measurements. In addition, during 
tissue growth and development, the compartmentalization 
of tissue water changes; such changes alter the degree of 
hydration, and can be visualized using MRI and quantified 
by MR-derived measurements. In the case of engineered 
bone, for example, water molecules become immobilized at 
charged surfaces, reducing T1, while mineral deposition es-
tablishes local regions of solid bone altering the local mag-
netic susceptibility, reducing T2. For engineered cartilage, 
collagen and proteoglycan deposition can be quantified by 
observing changes in the diffusion coefficient and MT val-
ues. In both cases, the integration of tissue-engineered con-
structs with the host tissue in vivo needs to be evaluated 
and the strength and stiffness of the implants assessed by 
MR elastography. Post-implant monitoring using MRI is 
crucial to ensure that the engineered constructs and regen-
erated tissues are functioning normally along with the host 
tissue.
MRI is also capable of assessing changes in the shape and 
size of the constructs that often occur during tissue develop-
ment. Such changes likely reflect normal growth consolida-
tion but they could also be due to non-uniform cell seeding 
in the scaffold. Since cell seeding density is highly corre-
lated with tissue development, better control of this process 
is needed. This problem has been recognized by tissue en-
gineers, as they work toward engineering tissues that retain 
a pre-defined shape. In a similar manner MRI can be used 
to identify and monitor the development of tissue structures 
such as the internal layers of articular cartilage and the an-
isotropy of diffusion in cartilage and muscle.
Finally in vivo monitoring of the transitional region be-
tween implants and the surrounding tissues is an active area 
of current research in tissue engineering and regenerative 
medicine. New high resolution MRI protocols for assessing 
cell proliferation in tissue engineering are a complement to 
established optical and micro-CT methods. In the future, im-
proved MR system capabilities should allow NMR spectros-
copy and MRI to play an increasing role in tissue engineer-
ing, and ultimately speed the development of regenerative 
medicine as an emerging clinical technique.
Figure 5. (A) A comparison of histological and MR images of natural 
fat and an MR image of engineered fat. For the engineered fat, the cells 
were stained for oil red-O to indicate lipid synthesis as red and coun-
terstained with hematoxylin to mark nuclei blue (25). (B) T2 relaxation 
time and shear stiffness data for engineered fat. Although the MR im-
ages and T2 measurements were not able to differentiate between the 
stages of adipogenesis, the elastography data showed a reduction in 
stiffness suggesting lipid formation. All data are represented by aver-
age ± std (sample size n = 3).
mOnitOring tissue engineering using mri   525
Acknowledgments — The authors wish to thank the follow-
ing colleagues for their assistance in preparing this paper: Dr. 
Liu Hong, Department of Orthodontics, College of Dentistry 
at the University of Illinois at Chicago, Dr. Robert A. Kleps, 
Director at the NMR Research Service Facility of the Research 
Resources Center at the University of Illinois at Chicago, Dr. 
Jeremy Mao, Department of Orthodontics at Columbia Uni-
versity, and Dr. Carol Muehleman, Department of Biochem-
istry at Rush University. We also gratefully acknowledge ed-
itorial assistance provided by Ms. Lynne Magin, Ms. Evelyn 
Esquivel and Mr. Lukasz Zientara.
References
1 M. J. Lysaght and J. A. O’Loughlin, Demographic scope and 
economic magnitude of contemporary organ replacement 
therapies, ASAIO J 46 (2000), pp. 515–521. 
2 F. Helmchen and W. Denk, Deep tissue two-photon micros-
copy, Nat Methods 2 (2005), pp. 932–940. 
3 A. B. Wolbarst, Physics of radiology, Medical Physics Publish-
ing, Madison, WI (1993). 
4 L. G. Griffith and G. Naughton, Tissue engineering—current 
challenges and expanding opportunities, Science 295 (2002), 
pp. 1009–1014. 
5 W. S. Pietrzak, Musculoskeletal tissue regeneration: biological 
materials and methods, Humana Press, Totowa, NJ (2008). 
6 M. Kino-oka, Y. Maeda, T. Yamamoto, K. Sugawara and M. 
Taya, A kinetic modeling of chondrocyte culture for man-
ufacture of tissue-engineered cartilage, J. Biosci. Bioeng. 99 
(2005), pp. 197–207. 
7 Y. Irie, H. Mizumoto, S. Fujino and T. Kajiwara, Reconstruc-
tion of cartilage tissue using scaffold-free organoid culture 
technique, J. Biosci. Bioeng. 105 (2008), pp. 450–453. 
8 J. S. Temenoff and A. G. Mikos, Review: tissue engineer-
ing for regeneration of articular cartilage, Biomaterials 21 
(2000), pp. 431–440. 
9 P. Bianco and P. G. Robey, Stem cells in tissue engineering, 
Nature 414 (2001), pp. 118–121. 
10 L. L. Hench and J. M. Polak, Third-generation biomedical 
materials, Science 295 (2002), pp. 1014–1017. 
11 C. T. Chen, K. W. Fishbein, P. A. Torzilli, A. Hilger, R. G. 
S. Spencer and W. E. Horton, Matrix fixed-charge density 
as determined by magnetic resonance microscopy of biore-
actor-derived hyaline cartilage correlates with biochemical 
and biomechanical properties, Arthritis Rheum. 48 (2003), 
pp. 1047–1056. 
12 D. D. Stark and W. G. Bradley, Magnetic resonance imaging 
(3rd ed. ), Mosby-Year Books, St. Louis (1999). 
13 V Kuperman, Magnetic resonance imaging: physical principles 
and applications, Academic Press, San Diego (2000). 
14 X. Hu and D. G. Norris, Advances in high-field magnetic 
resonance imaging, Annu. Rev. Biomed. Eng. 6 (2004), pp. 
157–184. 
15 I. K. Ko, H. T. Song, E. J. Cho, E. S. Lee, Y. M. Huh and J. S. 
Suh, In vivo MR imaging of tissue-engineered human mes-
enchymal stem cells transplanted to mouse: a preliminary 
study, Ann. Biomed. Eng. 35 (2007), pp. 101–108. 
16 P. J. Basser and D. K. Jones, Diffusion-tensor MRI: theory, 
experimental design and data analysis—a technical review, 
NMR Biomed. 15 (2002), pp. 456–467. 
17 S. D. Wolff and R. S. Balaban, Magnetization transfer con-
Figure 6. Schematic description of the process of tissue engineering with the correspondence between MR techniques and tissue properties identi-
fied at each growth stage.
526 Xu, Othman, & magin in J. of Bioscience and Bioengineering 106 (2008) 
trast (MTC) and tissue water proton relaxation in vivo, 
Magn. Reson. Med. 10 (1989), pp. 135–144. 
18 J. R. Wozniak and K. O. Lim, Advances in white matter im-
aging: a review of in vivo magnetic resonance methodol-
ogies and their applicability to the study of development 
and aging, Neurosci. Biobehav. Rev. 30 (2006), pp. 762–774. 
19 B. Brochet and V. Dousset, Pathological correlates of mag-
netization transfer imaging abnormalities in animal models 
and humans with multiple sclerosis, Neurology 53 (1999), 
pp. S12–S17. 
20 K. Potter, D. E. Sweet, P. Anderson, G. R. Davis, N. Isogai, 
S. Asamura, H. Kusuhara and W. J. Landis, Non-destruc-
tive studies of tissue-engineered phalanges by magnetic 
resonance microscopy and X-ray microtomography, Bone 
38 (2006), pp. 350–358. 
21 U. Duvvuri, S. R. Charagundla, S. B. Kudchodkar, J. H. 
Kaufman, J. B. Kneeland, R. Rizi, J. S. Leigh and R. Reddy, 
Human knee: in vivo T1rho-weighted MR imaging at 1. 
5 T—preliminary experience, Radiology 220 (2001), pp. 
822–826. 
22 U. Duvvuri, R. Reddy, S. D. Patel, J. H. Kaufman, J. B. Knee-
land and J. S. Leigh, T1rho-relaxation in articular cartilage: 
effects of enzymatic degradation, Magn. Reson. Med. 38 
(1997), pp. 863–867. 
23 K. Kuroda, K. Oshio, R. V. Mulkern and F. A. Jolesz, Op-
timization of chemical shift selective suppression of fat, 
Magn. Reson. Med. 40 (1998), pp. 505–510. 
24 R. Muthupillai, P. J. Rossman, D. J. Lomas, J. F. Greenleaf, S. 
J. Riederer and R. L. Ehman, Magnetic resonance imaging 
of transverse acoustic strain waves, Magn. Reson. Med. 36 
(1996), pp. 266–274. 
25 Y. Y. Cheung, M. Doyley, T. B. Miller, F. Kennedy, F. Lynch, 
J. S. Wrobel, K. Paulson and J. Weaver, Magnetic resonance 
elastography of the plantar fat pads preliminary study in 
diabetic patients and asymptomatic volunteers, J. Comput. 
Assist. Tomogr. 30 (2006), pp. 321–326. 
26 C. T. Laurencin, A. M. A. Ambrosio, M. D. Borden and J. 
A. Cooper, Tissue engineering: orthopedic applications, 
Annu. Rev. Biomed. Eng. 1 (1999), pp. 19–46. 
27 C. T. Laurencin, Y. Khan and S. F. El-Amin, Bone graft sub-
stitutes, Expert Rev. Med. Devices 3 (2006), pp. 49–57. 
28 A. J. Salgado, O. P. Coutinho and R. L. Reis, Bone tissue 
engineering: state of the art and future trends, Macromol. 
Biosci. 4 (2004), pp. 743–765. 
29 D. J. Tyler, M. D. Robson, R. M. Henkelman, I. R. Young 
and G. M. Bydder, Magnetic resonance imaging with ultra-
short TE (UTE) pulse sequences: technical considerations, 
J. Magn. Reson. 25 (2007), pp. 279–289. 
30 G. A. Ladinsky and F. W. Wehrli, Noninvasive assessment 
of bone microarchitecture by MRI, Curr. Osteoporos. Rep. 4 
(2006), pp. 140–147. 
31 F. W. Wehrli, H. K. Song, P. K. Saha and A. C. Wright, 
Quantitative MRI for the assessment of bone structure and 
function, NMR Biomed. 19 (2006), pp. 731–764. 
32 N. R. Washburn, M. Weir, P. Anderson and K. Potter, Bone 
formation in polymeric scaffolds evaluated by proton mag-
netic resonance microscopy and X-ray microtomography, 
J. Biomed. Mater. Res. 69 (2004), pp. 738–747. 
33 H. Xu, S. F. Othman, L. Hong, I. A. Peptan and R. L. Magin, 
Magnetic resonance microscopy for monitoring osteogen-
esis in tissue-engineered construct in vitro, Phys. Med. Biol. 
51 (2006), pp. 719–732. 
34 I. E. Chesnick, F. A. Avallone, R. D. Leapman, W. J. Landis, 
N. Eidelman and K. Potter, Evaluation of bioreactor-culti-
vated bone by magnetic resonance microscopy and FTIR 
microspectroscopy, Bone 40 (2007), pp. 904–912. 
35 S. F. Othman, H. Xu, T. J. Royston and R. L. Magin, Mi-
croscopic magnetic resonance elastography (microMRE), 
Magn. Reson. Med. 54 (2005), pp. 605–614. 
36 E. H. M. Hartman, J. A. Pikkemmat, J. W. M. Vehof, A. Heer-
schap, J. A. Jansen and P. H. M. Spauwen, In vivo magnetic 
resonance imaging explorative study of ectopic bone for-
mation in the rat, Tissue Eng. 8 (2002), pp. 1029–1036. 
37 A. De Ranieri, A. S. Virdi, S. Kuroda, K. E. Healy, N. J. Hal-
lab and D. R. Sumner, Saline irrigation does not affect bone 
formation or fixation strength of hydroxyapatite/trical-
cium phosphate-coated implants in a rat model, J. Biomed. 
Mater. Res. B: Appl. Mater. 74 (2005), pp. 712–717. 
38 V. B. Kraus, Pathogenesis and treatment of osteoarthritis, 
Med. Clin. North Am. 81 (1997), pp. 85–112. 
39 J. J. Mao, Stem-cell-driven regeneration of synovial joints, 
Biol. Cell 97 (2005), pp. 289–301. 
40 C. J. Wirth and M. Rudert, Techniques of cartilage growth 
enhancement: a review of the literature, Arthroscopy 12 
(1996), pp. 300–308. 
41 G. Meachim and R. A. Stockwell, The matrix. In: M. A. R. 
Freeman, Editor, Adult articular cartilage, Pitman Medical 
Publishing, London, UK (1979), pp. 1–50. 
42 B. Sharma and J. H. Elisseeff, Engineering structurally or-
ganized cartilage and bone tissues, Ann. Biomed. Eng. 32 
(2004), pp. 148–159. 
43 P. Angele, R. Kujat, M. Nerlich, J. Yoo, V. Goldberg and B. 
Johnstone, Engineering of osteochondral tissue with bone 
marrow mesenchymal progenitor cells in a derivatized hy-
aluronan-gelatin composite sponge, Tissue Eng. 5 (1999), 
pp. 545–554. 
44 E. J. Caterson, L. J. Nesti, W. J. Li, K. G. Danielson, J. J. Al-
bert, A. R. Vaccaro and R. S. Tuan, Three-dimensional car-
tilage formation by bone marrow-derived cells seeded in 
polylactide/alginate amalgam, J. Biomed. Mater. Res. 57 
(2001), pp. 394–403. 
45 K. H. Bouhadir, K. Y. Lee, E. Alsberg, K. L. Damn, K. W. 
Anderson and D. J. Mooney, Degradation of partially oxi-
dized alginate and its potential application for tissue engi-
neering, Biotechnol. Prog. 17 (2001), pp. 945–950. 
46 D. P. Speer, M. Chvapil, R. G. Volz and M. D. Holmes, En-
hancement of healing in osteochondral defects by colla-
gen sponge implants, Clin. Orthop. Rel. Res. 144 (1979), pp. 
326–335. 
47 K. Potter, J. J. Butler, C. Adams, K. W. Fishbein, E. W. Mc-
Farland, W. E. Horton and R. G. S. Spencer, Cartilage for-
mation in a hollow fiber bioreactor studied by proton mag-
netic resonance microscopy, Matrix Biol. 17 (1998), pp. 
513–523. 
48 S. F. Othman, J. Li, O. Abdullah, J. Moinness, R. L. Magin 
and C. Muehleman, High resolution/High contrast MRI 
of human articular cartilage lesions, Acta Orthop. 78 (2007), 
pp. 536–546. 
49 J. B. Greco and R. G. S. Spencer, Cartilage growth in mag-
netic resonance microscopy—compatible hollow fiber bio-
reactors. In: J. B. Chaudhuri and M. Al-Rubeai, Editors, Bio-
reactors for tissue engineering, Kluwer Academic Publishers, 
The Netherlands (2005), pp. 79–107. 
50 K. Potter, J. J. Butler, W. E. Horton and R. G. Spencer, Re-
mOnitOring tissue engineering using mri   527
sponse of engineered cartilage tissue to biochemical agents 
as studied by proton magnetic resonance microscopy, Ar-
thritis Rheum. 43 (2000), pp. 1580–1590. 
51 M. T. Nieminen, J. Rieppo, J. Toyras, J. M. Hakumaki, J. Sil-
vennoinen, M. M. Hyttinen, H. J. Helminen and J. S. Jurve-
lin, T2 Relaxation time reveals spatial collagen architecture 
in articular cartilage: a comparative quantitative MRI and 
polarized light microscopic study, Magn. Reson. Med. 46 
(2001), pp. 487–493. 
52 M. L. Gray, D. Burstein, L. M. Lesperance and L. Gehrke, 
Magnetization transfer in cartilage and its constituent mac-
romolecules, Magn. Reson. Med. 34 (1995), pp. 319–325. 
53 S. J. Ellis, M. Velayutham, S. S. Velan, E. F. Peterson, J. L. 
Zweier, P. Kuppusamy and R. G. S. Spencer, EPR oxygen 
mapping of engineered cartilage grown in a hollow-fiber 
bioreactor, Magn. Reson. Med. 46 (2001), pp. 819–826. 
54 A. A. Neves, N. Medcalf, M. Smith and K. M. Brindle, Eval-
uation of engineered meniscal cartilage constructs based 
on different scaffold geometries using magnetic resonance 
imaging and spectroscopy, Tissue Eng. 12 (2006), pp. 53–62. 
55 B. D. Foy and J. Blake, Diffusion of paramagnetically la-
beled proteins in cartilage: enhancement of the 1-D NMR 
imaging technique, J. Magn. Reson. 148 (2001), pp. 126–134. 
56 S. Ramaswamy, D. A. Wang, K. W. Fishbein, J. H. Elisseeff 
and R. G. S. Spencer, An analysis of the integration be-
tween articular cartilage and nondegradable hydrogel us-
ing magnetic resonance imaging, J. Biomed. Mater. Res. B. 
Appl. Biomater. 77 (2006), pp. 144–148. 
57 S. Miyata, T. Numano, K. Homma and T. Ushida, Feasibil-
ity of noninvasive evaluation of biophysical properties of 
tissue-engineered cartilage by using quantitative MRI, J. 
Biomech. 40 (2007), pp. 2990–2998. 
58 A. Watrin-Pinzano, J. P. Ruaud, Y. Cheli, P. Gonord, L. 
Grossin, I. Bettembourg-Brault, P. Gillet, E. Payan, G. Guil-
lot, P. Netter and D. Loeuille, Evaluation of cartilage repair 
tissue after biomaterial implantation in rat patella by using 
T2 mapping, MAGMA 17 (2004), pp. 219–228. 
59 K. Keinan-Adamsky, H. Shinar and G. Navon, Multinuclear 
NMR and MRI studies of the maturation of pig articular 
cartilage, Magn. Reson. Med. 55 (2006), pp. 532–540. 
60 S. Ramaswamy, I. Gurkan, B. Sharma, B. Cascio, K. W. Fish-
bein and R. G. Spencer, Assessment of tissue repair in full 
thickness chondral defects in the rabbit using magnetic 
resonance imaging transverse relaxation measurements, J. 
Biomed. Mater. Res. B: Appl. Biomater. 86 (2008), pp. 375–380. 
61 S. Ramaswamy, D. A. Wang, K. W. Fishbein, J. H. Elisseeff 
and R. G. Spencer, An analysis of the integration between 
articular cartilage and nondegradable hydrogel using mag-
netic resonance imaging, J. Biomed. Mater. Res. B: Appl. Bio-
mater. 77 (2006), pp. 144–148. 
62 S. Perry, T. L. Kowalski and C. H. Chang, Quality of life 
assessment in women with breast cancer: benefits, accept-
ability and utilization, Health Qual. Life Outcomes 5 (2007), 
pp. 24–38. 
63 E. A. Ojo-Amaize, M. S. Agopian and J. B. Peter, Novel in 
vitro method for identification of individuals at risk for be-
ryllium hypersensitivity, Clin. Diagn. Lab Immunol. 1 (1994), 
pp. 164–171. 
64 A. I. Caplan, Mesenchymal stem cells: cell-based recon-
structive therapy in orthopedics, Tissue Eng. 11 (2005), pp. 
1198–1211. 
65 L. Hong, I. A. Peptan, P. Clark and J. J. Mao, Ex vivo adi-
pose tissue engineering by human mesenchymal stem cell 
seeded gelatin sponge, Ann. Biomed. Eng. 33 (2005), pp. 
511–517. 
66 Q. S. Xiang, Two-point water-fat imaging with partially-
opposed-phase (POP) acquisition: an asymmetric Dixon 
method, Magn. Reson. Med. 56 (2006), pp. 572–584. 
